KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Sarepta Therapeutics (SRPT) Cost of Revenue (2017 - 2025)

Sarepta Therapeutics has reported Cost of Revenue over the past 9 years, most recently at $398.7 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 201.36% year-over-year to $398.7 million; the TTM value through Dec 2025 reached $839.6 million, up 163.12%, while the annual FY2025 figure was $839.6 million, 163.12% up from the prior year.
  • Cost of Revenue for Q4 2025 was $398.7 million at Sarepta Therapeutics, up from $150.8 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $398.7 million in Q4 2025 and troughed at $19.5 million in Q2 2021.
  • A 5-year average of $77.3 million and a median of $38.9 million in 2022 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: fell 9.71% in 2023 and later skyrocketed 242.48% in 2025.
  • Year by year, Cost of Revenue stood at $31.7 million in 2021, then fell by 2.98% to $30.8 million in 2022, then surged by 43.43% to $44.2 million in 2023, then surged by 199.49% to $132.3 million in 2024, then soared by 201.36% to $398.7 million in 2025.
  • Business Quant data shows Cost of Revenue for SRPT at $398.7 million in Q4 2025, $150.8 million in Q3 2025, and $152.6 million in Q2 2025.